GDF15 and Mitochondrial myopathy: GDF-15, a biomarker identified in the analysis of transcriptomic profiling of TK2 deficient human skeletal muscle [15], has been proven useful in the diagnosis of mitochondrial myopathies [16], being especially increased in patients with mitochondrial TK2 deficiency [17].